It is currently Wed May 27, 2015 1:01 pm

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

‘Personalised’ treatment results due next year

After the Phase 2b clinical trial achieved full enrolment with 190 secondary progress multiple sclerosis (SPMS) patients, Texas-based Opexa Therapeutics is now awaiting results for the company’s lead candidate, Tcelna, which are expected in the second half of 2016..... Read More -
Read more : ‘Personalised’ treatment results due next year | Views : 236 | Replies : 0

Opexa news: NMO

It looks like Opexa is working on a treatment for Neuromyelitis Optica. ... fault.aspx
Read more : Opexa news: NMO | Views : 564 | Replies : 0

Merck Serono Enter into Option and License for Tcelna

Opexa Therapeutics Inc. (OPXA) granted an exclusive license option to Germany-based Merck KGaA's (MKGAY, MRK.XE) biopharmaceutical division for the development and commercialization of Opexa's lead product candidate, Tcelna, for multiple sclerosis in a deal potentially valued at $225 million

They must see something of value?!?! ... 08051.html
Read more : Merck Serono Enter into Option and License for Tcelna | Views : 1257 | Replies : 2

Opexa reverse split

As I had predicted almost a year ago, on December 14th Opexa executed another reverse split. This time it was 1:4. Since then, their stock has fallen an additional 35.2% in value. This does not seem to put them in a good position for their ongoing trial of Tovaxin (Tcelna) with SPMS. ... cle=121412

Read more : Opexa reverse split | Views : 1383 | Replies : 0

Tcelna Trial for SPMS

Hello all. I am new to this forum. I was diagnosed with MS in 1999, and was able to work as a physician until last year. (Irony of Ironies...physician heal thyself!). I am looking to see whether I am a candidate to get on the Tcelna trial. Has anyone here already been selected? It is a double blind study, so what happens to those that end up in the placebo control group? In some studies, ...
Read more : Tcelna Trial for SPMS | Views : 9797 | Replies : 34

Recruiting Locations for TCelna (Tovaxin)

Looks like they at least have locations and some are even recruiting: ... exa&rank=3
Read more : Recruiting Locations for TCelna (Tovaxin) | Views : 1790 | Replies : 1

TCELNA 11B trial will start recruiting for the Abili-T trial

Drug previously know as "Tovaxin". Sounds like some patients have already been enrolled, and they are expecting to enroll more SPMS patients. I hope it turns out to be as promising as it sounds. ... 00862.html ... on=tovaxin
Read more : TCELNA 11B trial will start recruiting for the Abili-T trial | Views : 1577 | Replies : 0

Double barrel approach

So I understand that Tovaxin has been designed to work, by targeting T-Cells specifically involved in attacking Myelin. Now, on the other hand we have another treatment called Campath, which has shown some positive effectiveness by targeting CD52, a protein present on the surface of mature lymphocytes. I would think that the scientists would somehow also be able to train Tovaxin to also target CD52 as well as its current targets, and thereby combine the ...
Read more : Double barrel approach | Views : 1314 | Replies : 0

Opexa activity?

There was some interesting activity last Friday with Opexa's stock. However, I've been unable to find any news that might be related to it. I know that they're getting ready for their trial with SPMS patients, but was there some announcement that I missed?

Read more : Opexa activity? | Views : 1538 | Replies : 1

Tcelna announced as new brand name for MS therapy Tovaxin


Opexa Therapeutics, a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company is rebranding its leading MS therapy with the new name Tcelna(TM). The product, previously known as Tovaxin(R), will now be known as Tcelna as the company positions itself towards the treatment of patients with Secondary Progressive MS (SPMS).

"Opexa has worked diligently in the optimization of its overall manufacturing process and clinical development program while ...
Read more : Tcelna announced as new brand name for MS therapy Tovaxin | Views : 1501 | Replies : 0


Login  •  Register


Total posts 225634 • Total topics 23666 • Total members 15020

Contact us | Terms of Service